Chapter 38 Intracerebral hemorrhage

Handbook of Clinical Neurology

Volumn 93, Issue , 2008, Pages 767-790

  Viswanathan, Anand ^a   Greenberg, Steven M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD VESSEL; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; HUMAN; METHODOLOGY; PATHOLOGY; RISK FACTOR; ULTRASTRUCTURE;

BLOOD VESSELS; CEREBRAL ANGIOGRAPHY; CEREBRAL HEMORRHAGE; HUMANS; RISK FACTORS;

EID: 79952095423     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(08)93038-4     Document Type: Review

References (298)

1. Abbott R.D., Yin Y., Reed D.M., et al. Risk of stroke in male cigarette smokers. N Engl J Med 315 (1986) 717-720
2. Aggarwal S.K., Williams V., Levine S.R., et al. Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology 46 (1996) 1741-1743
3. Albers G.W., Sherman D.G., Gress D.R., et al. Stroke prevention in nonvalvular atrial fibrillation: a review of prospective randomized trials. Ann Neurol 30 (1991) 511-518
4. Alberts M.J., McCarron M.O., Hoffmann K.L., et al. Familial clustering of intracerebral hemorrhage: a prospective study in North Carolina. Neuroepidemiology 21 (2002) 18-21
5. Alonzo N.C., Hyman B.T., Rebeck G.W., et al. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 57 (1998) 353-359
6. American-Canadian Co-Operative Study Group. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. Stroke 16 (1985) 406-415
7. Anderson C.S., Chakera T.M., Stewart-Wynne E.G., et al. Spectrum of primary intracerebral haemorrhage in Perth, Western Australia, 1989-90: incidence and outcome. J Neurol Neurosurg Psychiatry 57 (1994) 936-940
8. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
9. Arakawa S., Saku Y., Ibayashi S., et al. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 29 (1998) 1806-1809
10. Arboix A., Massons J., Garcia-Eroles L., et al. Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care 23 (2000) 1527-1532
11. Aring C.D. Differential diagnosis of cerebrovascular stroke. Arch Intern Med 113 (1964) 195-199
12. Atlas S.W., Mark A.S., Grossman R.I., et al. Intracranial hemorrhage: gradient-echo MR imaging at 1.5 T. Comparison with spin-echo imaging and clinical applications. Radiology 168 (1988) 803-807
13. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154 (1994) 1449-1457
14. Auer L.M., Deinsberger W., Niederkorn K., et al. Endoscopic surgery versus medical treatment for spontaneous intracerebral hematoma: a randomized study. J Neurosurg 70 (1989) 530-535
15. Aurell M., and Head B. Cerebral hemorrhage in a population after a decade of active anti-hypertensive treatment. Acta Med Scand 176 (1964) 377
16. Babikian V.L., Kase C.S., Pessin M.S., et al. Intracerebral hemorrhage in stroke patients anticoagulated with heparin. Stroke 20 (1989) 1500-1503
17. Bailey R.D., Hart R.G., Benavente O., et al. Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 56 (2001) 773-777
18. Bamford J., Sandercock P., Dennis M., et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry 51 (1988) 1373-1380
19. Bamford J., Sandercock P., Dennis M., et al. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 53 (1990) 16-22
20. Barraquer-Bordas L., Illa I., Escartin A., et al. Thalamic hemorrhage. A study of 23 patients with diagnosis by computed tomography. Stroke 12 (1981) 524-527
21. Barron K.D., and Fergusson G. Intracranial hemorrhage as a complication of anticoagulant therapy. Neurology 9 (1959) 447-455
22. Batjer H.H., Reisch J.S., Allen B.C., et al. Failure of surgery to improve outcome in hypertensive putaminal hemorrhage. A prospective randomized trial. Arch Neurol 47 (1990) 1103-1106
23. Becker K.J., Baxter A.B., Cohen W.A., et al. Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology 56 (2001) 766-772
24. Bogousslavsky J., Van Melle G., Regli F., et al. The Lausanne stroke registry: analysis of 1,000 consecutive patients with first stroke. Stroke 19 (1988) 1083-1092
25. Bousser M.G., Eschwege E., Haguenau M., et al. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 14 (1983) 5-14
26. Bowers S.A., and Marshall L.F. Outcome in 200 consecutive cases of severe head injury treated in San Diego County: a prospective analysis. Neurosurgery 6 (1980) 237-242
27. Brewer D.B., Fawcett F.J., Horsfield G.I., et al. A necropsy series of non-traumatic cerebral haemorrhages and softenings, with particular reference to heart weight. J Pathol Bacteriol 96 (1968) 311-320
28. Broderick J.P., Phillips S.J., Whisnant J.P., et al. Incidence rates of stroke in the eighties: the end of the decline in stroke. Stroke 20 (1989) 577-582
29. Broderick J.P., Brott T., Tomsick T., et al. The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med 326 (1992) 733-736
30. Broderick J.P., Brott T., Tomsick T., et al. Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 78 (1993) 188-191
31. Broderick J.P., Brott T.G., Duldner J.E., et al. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality. Stroke 24 (1993) 987-993
32. Broderick J.P., Adams Jr. H.P., Barsan W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 30 (1999) 905-915
33. Brott T., Thalinger K., Hertzberg V., et al. Hypertension as a risk factor for spontaneous intracerebral hemorrhage. Stroke 17 (1986) 1078-1083
34. Brott T., Broderick J., Kothari R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28 (1997) 1-5
35. Bruno A., Carter S., Qualls C., et al. Incidence of spontaneous intracerebral hemorrhage among Hispanics and non-Hispanic whites in New Mexico. Neurology 47 (1996) 405-408
36. Bruno A., Levine S.R., Frankel M.R., et al. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology 59 (2002) 669-674
37. Camerlingo M., Casto L., Censori B., et al. Immediate anticoagulation with heparin for first-ever ischemic stroke in the carotid artery territories observed within 5 hours of onset. Arch Neurol 51 (1994) 462-467
38. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 299 (1978) 53-59
39. Carlberg B., Asplund K., Hagg E., et al. The prognostic value of admission blood pressure in patients with acute stroke. Stroke 24 (1993) 1372-1375
40. Cartmill M., Dolan G., Byrne J.L., et al. Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies. Br J Neurosurg 14 (2000) 458-461
41. Castano E.M., Prelli F., Soto C., et al. The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease. J Biol Chem 271 (1996) 32185-32191
42. Castillo J., Davalos A., Alvarez-Sabin J., et al. Molecular signatures of brain injury after intracerebral hemorrhage. Neurology 58 (2002) 624-629
43. Cerebral Embolism Study Group. Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Stroke 15 (1984) 779-789
44. Chamorro A., Vila N., Saiz A., et al. Early anticoagulation after large cerebral embolic infarction: a safety study. Neurology 45 (1995) 861-865
45. Charcot J.M., and Bouchard C. Nouvelle recherches sur la pathogenie de l'hemorrhagie cerebrale. Arch Physiol Norm Pathol 1 (1868) 643-645
46. Cho H.S., Hyman B.T., Greenberg S.M., et al. Quantitation of apoe domains in Alzheimer disease brain suggests a role for ApoE in Abeta aggregation. J Neuropathol Exp Neurol 60 (2001) 342-349
47. Clark W.M., Lyden P.D., Madden K.P., et al. Thrombolytic therapy in acute ischemic stroke. N Engl J Med 336 (1997) 65-66 author reply 66-67
48. Coplin W.M., Pierson D.J., Cooley K.D., et al. Implications of extubation delay in brain-injured patients meeting standard weaning criteria. Am J Respir Crit Care Med 161 (2000) 1530-1536
49. Dawson I., van Bockel J.H., Ferrari M.D., et al. Ischemic and hemorrhagic stroke in patients on oral anticoagulants after reconstruction for chronic lower limb ischemia. Stroke 24 (1993) 1655-1663
50. De Courten-Myers G.M., Kleinholz M., Holm P., et al. Hemorrhagic infarct conversion in experimental stroke. Ann Emerg Med 21 (1992) 120-126
51. Demchuk A.M., Morgenstern L.B., Krieger D.W., et al. Serum glucose level and diabetes predict tissue plasminogen activator-related intracerebral hemorrhage in acute ischemic stroke. Stroke 30 (1999) 34-39
52. Diener H.C., Cunha L., Forbes C., et al. European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143 (1996) 1-13
53. Dinsdale H.B. Spontaneous hemorrhage in the posterior fossa. A study of primary cerebellar and pontine hemorrhages with observations on their pathogenesis. Arch Neurol 10 (1964) 200-217
54. Diringer M.N. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med 21 (1993) 1591-1603
55. Diringer M.N., Edwards D.F., Zazulia A.R., et al. Hydrocephalus: a previously unrecognized predictor of poor outcome from supratentorial intracerebral hemorrhage. Stroke 29 (1998) 1352-1357
56. Donahue R.P., Abbott R.D., Reed D.M., et al. Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA 255 (1986) 2311-2314
57. Donnan G.A., Davis S.M., Chambers B.R., et al. Trials of streptokinase in severe acute ischaemic stroke. Lancet 345 (1995) 578-579
58. Drapkin A., and Merskey C. Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction. JAMA 222 (1972) 541-548
59. Drury I., Whisnant J.P., Garraway W.M., et al. Primary intracerebral hemorrhage: impact of CT on incidence. Neurology 34 (1984) 653-657
60. Eckman M.H., Rosand J., Knudsen K.A., et al. Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke 34 (2003) 1710-1716
61. Ellis R.J., Olichney J.M., Thal L.J., et al. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology 46 (1996) 1592-1596
62. ESPS Group. The European Stroke Prevention Study (ESPS). Principal end-points. Lancet 2 (1987) 1351-1354
63. Fazekas F., Kleinert R., Roob G., et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 20 (1999) 637-642
64. Fisher C.M. The pathologic and clinical aspects of thalamic hemorrhage. Trans Am Neurol Assoc 84 (1959) 56-59
65. Fisher C.M. Clinical syndromes in cerebral hemorrhages. In: Fields W.S. (Ed). Pathogenesis and Treatment of Cerebrovascular Disease (1961), Charles C. Thomas, Springfield, IL 318
66. Fisher C.M. The pathology and pathogenesis of intracerebral hemorrhage. In: Fields W.S. (Ed). Pathogenesis and Treatment of Cerebrovascular Disease (1961), Charles C. Thomas, Springfield, IL 295
67. Fisher C.M. Ocular bobbing. Arch Neurol 11 (1964) 543-546
68. Fisher C.M. Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 30 (1971) 536-550
69. Fisher C.M. Cerebral miliary aneurysms in hypertension. Am J Pathol 66 (1972) 313-330
70. Fisher C.M., Picard E.H., Polak A., et al. Acute hypertensive cerebellar hemorrhage: diagnosis and surgical treatment. J Nerv Ment Dis 140 (1965) 38-57
71. Flemming K.D., Wijdicks E.F., Li H., et al. Can we predict poor outcome at presentation in patients with lobar hemorrhage?. Cerebrovasc Dis 11 (2001) 183-189
72. Flibotte J.J., Hagan N., O'Donnell J., et al. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 63 (2004) 1059-1064
73. Fogelholm R., Nuutila M., Vuorela A.L., et al. Primary intracerebral haemorrhage in the Jyvaskyla region, central Finland, 1985-89: incidence, case fatality rate, and functional outcome. J Neurol Neurosurg Psychiatry 55 (1992) 546-552
74. Freytag E. Fatal hypertensive intracerebral haematomas: a survey of the pathological anatomy of 393 cases. J Neurol Neurosurg Psychiatry 31 (1968) 616-620
75. Fujii Y., Takeuchi S., Sasaki O., et al. Multivariate analysis of predictors of hematoma enlargement in spontaneous intracerebral hemorrhage. Stroke 29 (1998) 1160-1166
76. Furlan A.J., Whisnant J.P., Elveback L.R., et al. The decreasing incidence of primary intracerebral hemorrhage: a population study. Ann Neurol 5 (1979) 367-373
77. Garcia J.H., and Ho K.L. Pathology of hypertensive arteriopathy. Neurosurg Clin N Am 3 (1992) 497-507
78. Garraway W.M., Whisnant J.P., Drury I., et al. The continuing decline in the incidence of stroke. Mayo Clin Proc 58 (1983) 520-523
79. Gatchev O., Rastam L., Lindberg G., et al. Subarachnoid hemorrhage, cerebral hemorrhage, and serum cholesterol concentration in men and women. Ann Epidemiol 3 (1993) 403-409
80. Gebel J.M., and Broderick J.P. Intracerebral hemorrhage. Neurol Clin 18 (2000) 419-438
81. Gebel J.M., Sila C.A., Sloan M.A., et al. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Stroke 29 (1998) 563-569
82. Gebel Jr. J.M., Jauch E.C., Brott T.G., et al. Natural history of perihematomal edema in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33 (2002) 2631-2635
83. Gebel Jr. J.M., Jauch E.C., Brott T.G., et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33 (2002) 2636-2641
84. Giroud M., Gras P., Chadan N., et al. Cerebral haemorrhage in a French prospective population study. J Neurol Neurosurg Psychiatry 54 (1991) 595-598
85. Giroud M., Creisson E., Fayolle H., et al. Risk factors for primary cerebral hemorrhage: a population-based study-the Stroke Registry of Dijon. Neuroepidemiology 14 (1995) 20-26
86. Gore J.M., Sloan M., Price T.R., et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation 83 (1991) 448-459
87. Gore J.M., Granger C.B., Simoons M.L., et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. Circulation 92 (1995) 2811-2818
88. Gravina S.A., Ho L., Eckman C.B., et al. Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem 270 (1995) 7013-7016
89. Greenberg S.M. Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 51 (1998) 690-694
90. Greenberg S.M. Stroke: Pathophysiology, Diagnosis, and Management. Cerebral Amyloid Angiopathy (2004), Churchill Livingstone, Philadelphia 695
91. Greenberg S.M., Vonsattel J.P., et al. Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke 28 (1997) 1418-1422
92. Greenberg S.M., Rebeck G.W., Vonsattel J.P., et al. Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 38 (1995) 254-259
93. Greenberg S.M., Briggs M.E., Hyman B.T., et al. Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 27 (1996) 1333-1337
94. Greenberg S.M., Finklestein S.P., Schaefer P.W., et al. Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology 46 (1996) 1751-1754
95. Greenberg S.M., Vonsattel J.P., Segal A.Z., et al. Association of apolipoprotein E epsilon 2 and vasculopathy in cerebral amyloid angiopathy. Neurology 50 (1998) 961-965
96. Greenberg S.M., O'Donnell H.C., Schaefer P.W., et al. MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology 53 (1999) 1135-1138
97. Greene G.M., Godersky J.C., Biller J., et al. Surgical experience with cerebral amyloid angiopathy. Stroke 21 (1990) 1545-1549
98. Gress D.R., Diringer M.N., Green D., et al. In: Gress D.R., Diringer M.N., Green D., Mayer S.A., Bleck T.P., and Ropper A.H. (Eds). Neurological and Neurosurgical Intensive Care (2003), Raven Press, New York 38
99. Gross C.R., Kase C.S., Mohr J.P., et al. Stroke in south Alabama: incidence and diagnostic features-a population based study. Stroke 15 (1984) 249-255
100. Gujjar A.R., Deibert E., Manno E.M., et al. Mechanical ventilation for ischemic stroke and intracerebral hemorrhage: indications, timing, and outcome. Neurology 51 (1998) 447-451
101. Handley A.J., Emerson P.A., Fleming P.R., et al. Heparin in the prevention of deep vein thrombosis after myocardial infarction. BMJ 2 (1972) 436-438
102. Hansen B.S., and Marquardsen J. Incidence of stroke in Frederiksberg, Denmark. Stroke 8 (1977) 663-665
103. Hart R.G., and Pearce L.A. In vivo antithrombotic effect of aspirin: dose versus nongastrointestinal bleeding. Stroke 24 (1993) 138-139
104. Hart R.G., Boop B.S., Anderson D.C., et al. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 26 (1995) 1471-1477
105. He J., Whelton P.K., Vu B., et al. Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA 280 (1998) 1930-1935
106. Herman B., Schulte B.P., van Luijk J.H., et al. Epidemiology of stroke in Tilburg, The Netherlands. The population-based stroke incidence register: 1. Introduction and preliminary results. Stroke 11 (1980) 162-165
107. Herman B., Leyten A.C., van Luijk J.H., et al. Epidemiology of stroke in Tilburg, The Netherlands. The population-based stroke incidence register: 2. Incidence, initial clinical picture and medical care, and three-week case fatality. Stroke 13 (1982) 629-634
108. Hickenbottom S.L., Grotta J.C., Strong R., et al. Nuclear factor-kappa b and cell death after experimental intracerebral hemorrhage in rats. Stroke 30 (1999) 2472-2477 discussion 2477-2478
109. Hier D.B., Davis K.R., Richardson Jr. E.P., et al. Hypertensive putaminal hemorrhage. Ann Neurol 1 (1977) 152-159
110. Hylek E.M., and Singer D.E. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 120 (1994) 897-902
111. Iribarren C., Jacobs D.R., Sadler M., et al. Low total serum cholesterol and intracerebral hemorrhagic stroke: is the association confined to elderly men? The Kaiser Permanente Medical Care Program. Stroke 27 (1996) 1993-1998
112. Iso H., Jacobs Jr. D.R., Wentworth D., et al. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 320 (1989) 904-910
113. Itoh Y., Yamada M., Hayakawa M., et al. Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 116 (1993) 135-141
114. Iwatsubo T., Odaka A., Suzuki N., et al. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13 (1994) 45-53
115. Iwatsubo T., Mann D.M., Odaka A., et al. Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Ann Neurol 37 (1995) 294-299
116. Izumihara A., Ishihara T., Iwamoto N., et al. Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Stroke 30 (1999) 29-33
117. Jarrett J.T., Berger E.P., Lansbury Jr. P.T., et al. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32 (1993) 4693-4697
118. Jellinger K. Cerebrovascular amyloidosis with cerebral hemorrhage. J Neurol 214 (1977) 195-206
119. Juvela S., Hillbom M., Palomaki H., et al. Risk factors for spontaneous intracerebral hemorrhage. Stroke 26 (1995) 1558-1564
120. Kalaria R.N., and Kroon S.N. Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease. Biochem Biophys Res Commun 186 (1992) 461-466
121. Kase C.S. Cerebral amyloid angiopathy. In: Kase C.S., and Caplan L.R. (Eds). Intracerebral Hemorrhage (1994), Butterworth-Heinemann, Boston 179
122. Kase C.S., Williams J.P., Wyatt D.A., et al. Lobar intracerebral hematomas: clinical and CT analysis of 22 cases. Neurology 32 (1982) 1146-1150
123. Kase C.S., Robinson R.K., Stein R.W., et al. Anticoagulant-related intracerebral hemorrhage. Neurology 35 (1985) 943-948
124. Kase C.S., O'Neal A.M., Fisher M., et al. Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis. Ann Intern Med 112 (1990) 17-21
125. Kase C.S., Pessin M.S., Zivin J.A., et al. Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator. Am J Med 92 (1992) 384-390
126. Kase C.S., Furlan A.J., Wechsler L.R., et al. Cerebral hemorrhage after intra-arterial thrombolysis for ischemic stroke: the PROACT II trial. Neurology 57 (2001) 1603-1610
127. Kase C., Mohr J.P., Caplan L.R., et al. Intracerebral hemorrhage. In: Mohr J.P., Choi D.W., Grotta J., Weir B., and Wolf P.A. (Eds). Stroke: Pathophysiology, Diagnosis, and Management (2004), Churchill Livingstone, Philadelphia 327-376
128. Kazui S., Naritomi H., Yamamoto H., et al. Enlargement of spontaneous intracerebral hemorrhage. Incidence and time course. Stroke 27 (1996) 1783-1787
129. Kelley R.E., Berger J.R., Scheinberg P., et al. Active bleeding in hypertensive intracerebral hemorrhage: computed tomography. Neurology 32 (1982) 852-856
130. Kernan W.N., Viscoli C.M., Brass L.M., et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 343 (2000) 1826-1832
131. Kidwell C.S., Saver J.L., Mattiello J., et al. Diffusion- perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. Neurology 57 (2001) 1611-1617
132. Kidwell C.S., Chalela J.A., Saver J.L., et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292 (2004) 1823-1830
133. Kikta D.G., Devereaux M.W., Chandar K., et al. Intracranial hemorrhages due to phenylpropanolamine. Stroke 16 (1985) 510-512
134. Kirollos R.W., Tyagi A.K., Ross S.A., et al. Management of spontaneous cerebellar hematomas: a prospective treatment protocol?. Neurosurgery 49 (2001) 1378-1386 discussion 1386-1377
135. Kita Y., Okayama A., Ueshima H., et al. Stroke incidence and case fatality in Shiga, Japan 1989-1993. Int J Epidemiol 28 (1999) 1059-1065
136. Knudsen K.A., Rosand J., Karluk D., et al. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 56 (2001) 537-539
137. Kobayashi S., Sato A., Kageyama Y., et al. Treatment of hypertensive cerebellar hemorrhage-surgical or conservative management?. Neurosurgery 34 (1994) 246-250
138. Kubota M., Yamaura A., Ono J., et al. Is family history an independent risk factor for stroke?. J Neurol Neurosurg Psychiatry 62 (1997) 66-70
139. Kunimatsu A., Aoki S., Masutani Y., et al. Three-dimensional white matter tractography by diffusion tensor imaging in ischaemic stroke involving the corticospinal tract. Neuroradiology 45 (2003) 532-535
140. Kunitz S.C., Gross C.R., Heyman A., et al. The pilot-Stroke Data Bank: definition, design, and data. Stroke 15 (1984) 740-746
141. Kurth T., Kase C.S., Berger K., et al. Smoking and risk of hemorrhagic stroke in women. Stroke 34 (2003) 2792-2795
142. Kurth T., Kase C.S., Berger K., et al. Smoking and the risk of hemorrhagic stroke in men. Stroke 34 (2003) 1151-1155
143. Kurzke J.F. Epidemiology of Cerebrovascular Disease (1969), Springer-VerlagBerlin
144. Kwak R., Kadoya S., Suzuki T., et al. Factors affecting the prognosis in thalamic hemorrhage. Stroke 14 (1983) 493-500
145. Lake C.R., Gallant S., Masson E., et al. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports. Am J Med 89 (1990) 195-208
146. Landefeld C.S., and Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. Am J Med 87 (1989) 144-152
147. Leblanc R., Preul M., Robitaille Y., et al. Surgical considerations in cerebral amyloid angiopathy. Neurosurgery 29 (1991) 712-718
148. Lee S.S., and Stemmermann G.N. Congophilic angiopathy and cerebral hemorrhage. Arch Pathol Lab Med 102 (1978) 317-321
149. Lee K.R., Betz A.L., Keep R.F., et al. Intracerebral infusion of thrombin as a cause of brain edema. J Neurosurg 83 (1995) 1045-1050
150. Lee K.R., Betz A.L., Kim S., et al. The role of the coagulation cascade in brain edema formation after intracerebral hemorrhage. Acta Neurochir (Wien) 138 (1996) 396-400 discussion 400-391
151. Lee K.R., Colon G.P., Betz A.L., et al. Edema from intracerebral hemorrhage: the role of thrombin. J Neurosurg 84 (1996) 91-96
152. Lee K.R., Drury I., Vitarbo E., et al. Seizures induced by intracerebral injection of thrombin: a model of intracerebral hemorrhage. J Neurosurg 87 (1997) 73-78
153. Lee K.R., Kawai N., Kim S., et al. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 86 (1997) 272-278
154. Lemere C.A., Blusztajn J.K., Yamaguchi H., et al. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis 3 (1996) 16-32
155. Levine S.R., Brust J.C., Futrell N., et al. Cerebrovascular complications of the use of the "crack" form of alkaloidal cocaine. N Engl J Med 323 (1990) 699-704
156. Lin C.P., Wedeen V.J., Chen J.H., et al. Validation of diffusion spectrum magnetic resonance imaging with manganese-enhanced rat optic tracts and ex vivo phantoms. Neuroimage 19 (2003) 482-495
157. Lindenstrom E., Boysen G., Nyboe J., et al. Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ 309 (1994) 11-15
158. Linfante I., Llinas R.H., Caplan L.R., et al. MRI features of intracerebral hemorrhage within 2 hours from symptom onset. Stroke 30 (1999) 2263-2267
159. Lisk D.R., Pasteur W., Rhoades H., et al. Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 44 (1994) 133-139
160. Maat-Schieman M.L., van Duinen S.G., Rozemuller A.J., et al. Association of vascular amyloid beta and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease. J Neuropathol Exp Neurol 56 (1997) 273-284
161. Maeda A., Yamada M., Itoh Y., et al. Computer-assisted three-dimensional image analysis of cerebral amyloid angiopathy. Stroke 24 (1993) 1857-1864
162. Mak K., Yang F., Vinters H.V., et al. Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum. Brain Res 667 (1994) 138-142
163. Mandybur T.I. Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol 45 (1986) 79-90
164. Mann D.M., Iwatsubo T., Ihara Y., et al. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene. Am J Pathol 148 (1996) 1257-1266
165. Manno E.M., Atkinson J.L., Fulgham J.R., et al. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc 80 (2005) 420-433
166. Marshall L.F., Becker D.P., Bowers S.A., et al. The National Traumatic Coma Data Bank. Part 1: Design, purpose, goals, and results. J Neurosurg 59 (1983) 276-284
167. Marti-Vilalta J.L., and Adria Arboix Mohr J.P. Lacunes, Stroke: Pathophysiology, Diagnosis, and Management. 4th edn (2004), Churchill Livingstone, Philadelphia 279
168. Massaro A.R., Sacco R.L., Mohr J.P., et al. Clinical discriminators of lobar and deep hemorrhages: the Stroke Data Bank. Neurology 41 (1991) 1881-1885
169. Massaro A.R., Sacco R.L., Scaff M., et al. Clinical discriminators between acute brain hemorrhage and infarction: a practical score for early patient identification. Arq Neuropsiquiatr 60 (2002) 185-191
170. Masuda J., Tanaka K., Ueda K., et al. Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 19 (1988) 205-210
171. Mathew P., Teasdale G., Bannan A., et al. Neurosurgical management of cerebellar haematoma and infarct. J Neurol Neurosurg Psychiatry 59 (1995) 287-292
172. Matkovic Z., Davis S., Gonzales M., et al. Surgical risk of hemorrhage in cerebral amyloid angiopathy. Stroke 22 (1991) 456-461
173. Mayer S.A. Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 34 (2003) 224-229
174. Mayer S.A., Sacco R.L., Shi T., et al. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology 44 (1994) 1379-1384
175. Mayer S.A., Lignelli A., Fink M.E., et al. Perilesional blood flow and edema formation in acute intracerebral hemorrhage: a SPECT study. Stroke 29 (1998) 1791-1798
176. McCarron M.O., Nicoll J.A., Stewart J., et al. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 58 (1999) 711-718
177. Mckissock W., Richardson A., Taylor J., et al. Primary intracerebral haemorrhage: a Controlled Trial of Surgical and Conservative Treatment in 180 Unselected Cases. Lancet 278 (1961) 221-226
178. Meigs J.B., Mittleman M.A., Nathan D.M., et al. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA 283 (2000) 221-228
179. Mendelow A.D., Gregson B.A., Fernandes H.M., et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): a randomised trial. Lancet 365 (2005) 387-397
180. Miller D.W., Barnett G.H., Kormos D.W., et al. Stereotactically guided thrombolysis of deep cerebral hemorrhage: preliminary results. Cleve Clin J Med 60 (1993) 321-324
181. Minakawa T., Takeuchi S., Sasaki O., et al. Surgical experience with massive lobar haemorrhage caused by cerebral amyloid angiopathy. Acta Neurochir (Wien) 132 (1995) 48-52
182. Mohr J.P., Watters W.C., Duncan G.W., et al. Thalamic hemorrhage and aphasia. Brain Lang 2 (1975) 3-17
183. Mohr J.P., Caplan L.R., Melski J.W., et al. The Harvard Cooperative Stroke Registry: a prospective registry. Neurology 28 (1978) 754-762
184. Montes J.M., Wong J.H., Fayad P.B., et al. Stereotactic computed tomographic-guided aspiration and thrombolysis of intracerebral hematoma: protocol and preliminary experience. Stroke 31 (2000) 834-840
185. Morgenstern L.B., Frankowski R.F., Shedden P., et al. Surgical treatment for intracerebral hemorrhage (STICH): a single-center, randomized clinical trial. Neurology 51 (1998) 1359-1363
186. Morgenstern L.B., Demchuk A.M., Kim D.H., et al. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 56 (2001) 1294-1299
187. Morgenstern L.B., Smith M.A., Lisabeth L.D., et al. Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol 160 (2004) 376-383
188. Multicenter Acute Stroke Trial-Europe Study Group. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med 335 (1996) 145-150
189. Multicentre Acute Stroke Trial-Italy (MAST-I) Group. Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Lancet 346 (1995) 1509-1514
190. Mutlu N., Berry R.G., Alpers B.J., et al. Massive cerebral hemorrhage: clinical and pathological correlations. Arch Neurol 8 (1963) 74
191. Namba Y., Tomonaga M., Kawasaki H., et al. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 541 (1991) 163-166
192. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
193. Natte R., Vinters H.V., Maat-Schieman M.L., et al. Microvasculopathy is associated with the number of cerebrovascular lesions in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Stroke 29 (1998) 1588-1594
194. Natte R., Yamaguchi H., Maat-Schieman M.L., et al. Ultrastructural evidence of early non-fibrillar Abeta42 in the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type. Acta Neuropathol (Berl) 98 (1999) 577-582
195. Nicoll J.A., Burnett C., Love S., et al. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 41 (1997) 716-721
196. NINDS Stroke Workshop Participants. Priorities for clinical research in intracerebral hemorrhage: report from a National Institute of Neurological Disorders and Stroke workshop. Stroke 36 (2005) e23-e41
197. NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. NINDS t-PA Stroke Study Group. Stroke 28 (1997) 2109-2118
198. Nolte K.B., Brass L.M., Fletterick C.F., et al. Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology 46 (1996) 1291-1296
199. O'Donnell H.C., Rosand J., Knudsen K.A., et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 342 (2000) 240-245
200. Ojemann R.G., and Mohr J.P. Hypertensive brain hemorrhage. Clin Neurosurg 23 (1976) 220-244
201. Ojemann R.G., and Heros R.C. Spontaneous brain hemorrhage. Stroke 14 (1983) 468-475
202. Okada H., Horibe H., Yoshiyuki O., et al. A prospective study of cerebrovascular disease in Japanese rural communities, Akabane and Asahi. Part 1: Evaluation of risk factors in the occurrence of cerebral hemorrhage and thrombosis. Stroke 7 (1976) 599-607
203. Olichney J.M., Hansen L.A., Galasko D., et al. The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47 (1996) 190-196
204. Ott K.H., Kase C.S., Ojemann R.G., et al. Cerebellar hemorrhage: diagnosis and treatment. A review of 56 cases. Arch Neurol 31 (1974) 160-167
205. Passero S., Burgalassi L., D'Andrea P., et al. Recurrence of bleeding in patients with primary intracerebral hemorrhage. Stroke 26 (1995) 1189-1192
206. Passero S., Ciacci G., Ulivelli M., et al. The influence of diabetes and hyperglycemia on clinical course after intracerebral hemorrhage. Neurology 61 (2003) 1351-1356
207. Pendlebury W.W., Iole E.D., Tracy R.P., et al. Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment. Ann Neurol 29 (1991) 210-213
208. Peterson P.L., Roszler M., Jacobs I., et al. Neurovascular complications of cocaine abuse. J Neuropsychiatry Clin Neurosci 3 (1991) 143-149
209. Piriyawat P., Morgenstern L.B., Yawn D.H., et al. Treatment of Acute Intracerebral Hemorrhage with Aminocaproic Acid: A Pilot Study. Neurocrit Care 1 (2004) 47-52
210. Portenoy R.K., Lipton R.B., Berger A.R., et al. Intracerebral haemorrhage: a model for the prediction of outcome. J Neurol Neurosurg Psychiatry 50 (1987) 976-979
211. Powers W.J., Zazulia A.R., Videen T.O., et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 57 (2001) 18-24
212. Premkumar D.R., Cohen D.L., Hedera P., et al. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 148 (1996) 2083-2095
213. Progress Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358 (2001) 1033-1041
214. Qureshi A.I., Bliwise D.L., Bliwise N.G., et al. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med 27 (1999) 480-485
215. Qureshi A.I., Wilson D.A., Hanley D.F., et al. Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. Crit Care Med 27 (1999) 965-971
216. Qureshi A.I., Ling G.S., Khan J., et al. Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage. Crit Care Med 29 (2001) 152-157
217. Qureshi A.I., Ali Z., Suri M.F., et al. Extracellular glutamate and other amino acids in experimental intracerebral hemorrhage: an in vivo microdialysis study. Crit Care Med 31 (2003) 1482-1489
218. Radberg J.A., Olsson J.E., Radberg C.T., et al. Prognostic parameters in spontaneous intracerebral hematomas with special reference to anticoagulant treatment. Stroke 22 (1991) 571-576
219. Riegert-Johnson D.L., and Volcheck G.W. The incidence of anaphylaxis following intravenous phytonadione (vitamin K1): a 5-year retrospective review. Ann Allergy Asthma Immunol 89 (2002) 400-406
220. Rohde V., Rohde I., Reinges M.H., et al. Frameless stereotactically guided catheter placement and fibrinolytic therapy for spontaneous intracerebral hematomas: technical aspects and initial clinical results. Minim Invasive Neurosurg 43 (2000) 9-17
221. Roob G., Lechner A., Schmidt R., et al. Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke 31 (2000) 2665-2669
222. Ropper A.H., and Davis K.R. Lobar cerebral hemorrhages: acute clinical syndromes in 26 cases. Ann Neurol 8 (1980) 141-147
223. Rosand J., Hylek E.M., O'Donnell H.C., et al. Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 55 (2000) 947-951
224. Rosand J., Eskey C., Chang Y., et al. Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage. Cerebrovasc Dis 14 (2002) 214-220
225. Rosand J., Eckman M.H., Knudsen K.A., et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164 (2004) 880-884
226. Rosand J., Eckman M.H., Knudsen K.A., et al. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med 164 (2004) 880-884
227. Rosand J., Muzikansky A., Kumar A., et al. Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol 58 (2005) 459-462
228. Sacco R.L., Wolf P.A., Bharucha N.E., et al. Subarachnoid and intracerebral hemorrhage: natural history, prognosis, and precursive factors in the Framingham Study. Neurology 34 (1984) 847-854
229. Schmechel D.E., Saunders A.M., Strittmatter W.J., et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 90 (1993) 9649-9653
230. Schutz H., Bodeker R.H., Damian M., et al. Age-related spontaneous intracerebral hematoma in a German community. Stroke 21 (1990) 1412-1418
231. Segal A.Z., Chiu R.I., Eggleston-Sexton P.M., et al. Low cholesterol as a risk factor for primary intracerebral hemorrhage: a case-control study. Neuroepidemiology 18 (1999) 185-193
232. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399 (1999) A23-A31
233. Shinkai Y., Yoshimura M., Ito Y., et al. Amyloid beta-proteins 1-40 and 1-42(43) in the soluble fraction of extra- and intracranial blood vessels. Ann Neurol 38 (1995) 421-428
234. Siddique M.S., and Mendelow A.D. Surgical treatment of intracerebral haemorrhage. Br Med Bull 56 (2000) 444-456
235. Siddique M.S., Fernandes H.M., Arene N.U., et al. Changes in cerebral blood flow as measured by HMPAO SPECT in patients following spontaneous intracerebral haemorrhage. Acta Neurochir Suppl 76 (2000) 517-520
236. Sloan M.A., Price T.R., Petito C.K., et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology 45 (1995) 649-658
237. Sloan M.A., Sila C.A., Mahaffey K.W., et al. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation 98 (1998) 1376-1382
238. Smith E.E., Rosand J., Knudsen K.A., et al. Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke. Neurology 59 (2002) 193-197
239. Snow A.D., Mar H., Nochlin D., et al. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137 (1990) 1253-1270
240. Snyder M., and Renaudin J. Intracranial hemorrhage associated with anticoagulation therapy. Surg Neurol 7 (1977) 31-34
241. Song E.C., Chu K., Jeong S.W., et al. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke 34 (2003) 2215-2220
242. Stebbens W.E. Pathology of the Cerebral Blood Vessels (1972), CV Mosby, St. Louis
243. St Louis E.K., Wijdicks E.F., Li H., et al. Predicting neurologic deterioration in patients with cerebellar hematomas. Neurology 51 (1998) 1364-1369
244. St Louis E.K., Wijdicks E.F., Li H., et al. Predictors of poor outcome in patients with a spontaneous cerebellar hematoma. Can J Neurol Sci 27 (2000) 32-36
245. Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 42 (1997) 857-865
246. Susac J.O., Hoyt W.F., Daroff R.B., et al. Clinical spectrum of ocular bobbing. J Neurol Neurosurg Psychiatry 33 (1970) 771-775
247. Tanaka A., Ueno Y., Nakayama Y., et al. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas. Stroke 30 (1999) 1637-1642
248. Tanaka H., Ueda Y., Date C., et al. Incidence of stroke in Shibata, Japan: 1976-1978. Stroke 12 (1981) 460-466
249. Tanaka H., Ueda Y., Hayashi M., et al. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke 13 (1982) 62-73
250. Teernstra O.P., Evers S.M., Lodder J., et al. Stereotactic treatment of intracerebral hematoma by means of a plasminogen activator: a multicenter randomized controlled trial (SICHPA). Stroke 34 (2003) 968-974
251. Tellez H., and Bauer R.B. Dexamethasone as treatment in cerebrovascular disease. 1. A controlled study in intracerebral hemorrhage. Stroke 4 (1973) 541-546
252. Thrift A.G., McNeil J.J., Forbes A., et al. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension 31 (1998) 1223-1229
253. TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med 320 (1989) 618-627
254. Tomonaga M. Cerebral amyloid angiopathy in the elderly. J Am Geriatr Soc 29 (1981) 151-157
255. Tsushima Y., Tamura T., Unno Y., et al. Multifocal low-signal brain lesions on T2*-weighted gradient-echo imaging. Neuroradiology 42 (2000) 499-504
256. Tuhrim S., Dambrosia J.M., Price T.R., et al. Prediction of intracerebral hemorrhage survival. Ann Neurol 24 (1988) 258-263
257. Tuhrim S., Horowitz D.R., Sacher M., et al. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med 27 (1999) 617-621
258. Uchihara T., Akiyama H., Kondo H., et al. Activated microglial cells are colocalized with perivascular deposits of amyloid-beta protein in Alzheimer's disease brain. Stroke 28 (1997) 1948-1950
259. Ueda K., Omae T., Hirota Y., et al. Decreasing trend in incidence and mortality from stroke in Hisayama residents, Japan. Stroke 12 (1981) 154-160
260. Ueda K., Fukushima H., Masliah E., et al. Molecular cloning of cdna encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci USA 90 (1993) 11282-11286
261. Ueshima H., Iida M., Shimamoto T., et al. Multivariate analysis of risk factors for stroke. Eight-year follow-up study of farming villages in Akita, Japan. Prev Med 9 (1980) 722-740
262. UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Br Med J (Clin Res Ed) 296 (1988) 316-320
263. Unwin D.H., Giller C.A., Kopitnik T.A., et al. Central nervous system monitoring. What helps, what does not. Surg Clin North Am 71 (1991) 733-747
264. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
265. Verbeek M.M., Eikelenboom P., de Waal R.M., et al. Differences between the pathogenesis of senile plaques and congophilic angiopathy in Alzheimer disease. J Neuropathol Exp Neurol 56 (1997) 751-761
266. Vespa P.M., O'Phelan K., Shah M., et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 60 (2003) 1441-1446
267. Vinters H.V. Cerebral amyloid angiopathy. A critical review. Stroke 18 (1987) 311-324
268. Vinters H.V., and Gilbert J.J. Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 14 (1983) 924-928
269. Vinters H.V., Nishimura G.S., Secor D.L., et al. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. Am J Pathol 137 (1990) 233-240
270. Vinters H.V., Natte R., Maat-Schieman M.L., et al. Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D). Acta Neuropathol (Berl) 95 (1998) 235-244
271. Viswanathan A., Rakich S.M., Engel C., et al. Antiplatelet use after intracerebral hemorrhage. Neurology 66 (2006) 206-209
272. Vonsattel J.P., Myers R.H., Hedley-Whyte E.T., et al. Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 30 (1991) 637-649
273. Wagner K.R., Xi G., Hua Y., et al. Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter. Stroke 27 (1996) 490-497
274. Walshe T.M., Davis K.R., Fisher C.M., et al. Thalamic hemorrhage: a computed tomographic-clinical correlation. Neurology 27 (1977) 217-222
275. Weisberg L.A. Computerized tomography in intracranial hemorrhage. Arch Neurol 36 (1979) 422-426
276. Weisberg L.A. Subcortical lobar intracerebral haemorrhage: clinical-computed tomographic correlations. J Neurol Neurosurg Psychiatry 48 (1985) 1078-1084
277. Wiggins W.S., Moody D.M., Toole J.F., et al. Clinical and computerized tomographic study of hypertensive intracerebral hemorrhage. Arch Neurol 35 (1978) 832-833
278. Wijdicks E.F., and Jack Jr. C.R. Intracerebral hemorrhage after fibrinolytic therapy for acute myocardial infarction. Stroke 24 (1993) 554-557
279. Williams S.B., Goldfine A.B., Timimi F.K., et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97 (1998) 1695-1701
280. Wintzen A.R., de Jonge H., Loeliger E.A., et al. The risk of intracerebral hemorrhage during oral anticoagulant treatment: a population study. Ann Neurol 16 (1984) 553-558
281. Wong K.S. Risk factors for early death in acute ischemic stroke and intracerebral hemorrhage: a prospective hospital-based study in Asia. Asian Acute Stroke Advisory Panel. Stroke 30 (1999) 2326-2330
282. Woo D., and Broderick J.P. Spontaneous intracerebral hemorrhage: epidemiology and clinical presentation. Neurosurg Clin N Am 13 (2002) 265-279
283. Woo D., Sauerbeck L.R., Kissela B.M., et al. Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke 33 (2002) 1190-1195
284. Xi G., Wagner K.R., Keep R.F., et al. Role of blood clot formation on early edema development after experimental intracerebral hemorrhage. Stroke 29 (1998) 2580-2586
285. Xi G., Hua Y., Bhasin R.R., et al. Mechanisms of edema formation after intracerebral hemorrhage: effects of extravasated red blood cells on blood flow and blood-brain barrier integrity. Stroke 32 (2001) 2932-2938
286. Xi G., Hua Y., Keep R.F., et al. Systemic complement depletion diminishes perihematomal brain edema in rats. Stroke 32 (2001) 162-167
287. Xi G., Keep R.F., Hoff J.T., et al. Pathophysiology of brain edema formation. Neurosurg Clin N Am 13 (2002) 371-383
288. Yamada M., Itoh Y., Shintaku M., et al. Immune reactions associated with cerebral amyloid angiopathy. Stroke 27 (1996) 1155-1162
289. Yang Q.D., Niu Q., Zhou Y.H., et al. Incidence of cerebral hemorrhage in the Changsha community. A prospective study from 1986 to 2000. Cerebrovasc Dis 17 (2004) 303-313
290. Yano K., Reed D.M., MacLean C.J., et al. Serum cholesterol and hemorrhagic stroke in the Honolulu Heart Program. Stroke 20 (1989) 1460-1465
291. Yasaka M., Oomura M., Ikeno K., et al. Effect of prothrombin complex concentrate on INR and blood coagulation system in emergency patients treated with warfarin overdose. Ann Hematol 82 (2003) 121-123
292. Young W.B., Lee K.P., Pessin M.S., et al. Prognostic significance of ventricular blood in supratentorial hemorrhage: A volumetric study. Neurology 40 (1990) 616-619
293. Yu Y.L., Kumana C.R., Lauder I.J., et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double-blind, placebo-controlled, randomized trial. Stroke 23 (1992) 967-971
294. Zazulia A.R., Diringer M.N., Derdeyn C.P., et al. Progression of mass effect after intracerebral hemorrhage. Stroke 30 (1999) 1167-1173
295. Zazulia A.R., Diringer M.N., Videen T.O., et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 21 (2001) 804-810
296. Zhu X.L., Chan M.S., Poon W.S., et al. Spontaneous intracranial hemorrhage: which patients need diagnostic cerebral angiography? A prospective study of 206 cases and review of the literature. Stroke 28 (1997) 1406-1409
297. Zodpey S.P., Tiwari R.R., Kulkarni H.R., et al. Risk factors for haemorrhagic stroke: a case-control study. Public Health 114 (2000) 177-182
298. Zuccarello M., Brott T., Derex L., et al. Early surgical treatment for supratentorial intracerebral hemorrhage: A randomized feasibility study. Stroke 30 (1999) 1833-1839